Last $27.40 USD
Change Today -0.15 / -0.54%
Volume 830.8K
ASGN On Other Exchanges
Symbol
Exchange
New York
Frankfurt
As of 8:04 PM 09/19/14 All times are local (Market data is delayed by at least 15 minutes).

on assignment inc (ASGN) Snapshot

Open
$27.62
Previous Close
$27.55
Day High
$28.00
Day Low
$27.25
52 Week High
04/1/14 - $39.86
52 Week Low
07/31/14 - $26.23
Market Cap
1.5B
Average Volume 10 Days
616.6K
EPS TTM
$1.40
Shares Outstanding
54.5M
EX-Date
--
P/E TM
19.6x
Dividend
--
Dividend Yield
--
Current Stock Chart for ON ASSIGNMENT INC (ASGN)

on assignment inc (ASGN) Related Bloomberg News

View More Bloomberg News

on assignment inc (ASGN) Related Businessweek News

View More BusinessWeek News

on assignment inc (ASGN) Details

On Assignment, Inc. provides short- and long-term placement of contract, contract-to-hire, and direct hire professionals in the United States, Europe, Canada, China, Australia, and New Zealand. The company operates in four segments: Apex, Oxford, Life Sciences, and Physician. The Apex segment provides mission-critical information technology (IT) operations professionals for contract, contract-to-hire, and permanent placement positions to Fortune 1000 and mid-market clients, as well as offers consulting services for other select project-based needs. This segment provides staffing and services support for companies from various industries, including financial services, business services, consumer and industrials, technology, healthcare, government services, and communications. The Oxford segment provides high-end contract and direct placement services of IT and engineering professionals with expertise in specialized IT; software and hardware engineering; and mechanical, electrical, validation, and telecommunications engineering fields. The Life Sciences segment offers contract, contract-to-permanent, and direct placement services of laboratory and scientific professionals to the biotechnology, pharmaceutical, food and beverage, medical device, personal care, chemical, and environmental industries. Its contract staffing specialties include chemists, clinical research associates, clinical lab assistants, engineers, biologists, biochemists, microbiologists, molecular biologists, food scientists, regulatory affairs specialists, lab assistants, and other scientific professionals. The Physician segment offers contract and direct placement physicians to healthcare organizations; and places physicians in hospitals; community-based practices; and federal, state, and local facilities. The company was founded in 1985 and is headquartered in Calabasas, California.

2,700 Employees
Last Reported Date: 03/3/14
Founded in 1985

on assignment inc (ASGN) Top Compensated Officers

Chief Executive Officer, President, Director ...
Total Annual Compensation: $799.6K
Chief Financial Officer, Principal Accounting...
Total Annual Compensation: $455.9K
Chief Operating Officer and President of Oxfo...
Total Annual Compensation: $570.9K
President of Apex Systems Inc
Total Annual Compensation: $650.0K
Chief Administrative Officer and Senior Vice ...
Total Annual Compensation: $335.6K
Compensation as of Fiscal Year 2013.

on assignment inc (ASGN) Key Developments

On Assignment Inc. Reports Unaudited Consolidated Earnings Results for the Second Quarter and Six Months Ended June 30, 2014; Provides Earnings Guidance for the Third Quarter of 2014; Revises Earnings Guidance for the Full Year of 2014

On Assignment Inc. reported unaudited consolidated earnings results for the second quarter and six months ended June 30, 2014. For the quarter, the company reported revenues of $468,618,000 compared to $407,864,000 a year ago. Operating income was $38,648,000 compared to $31,775,000 a year ago. Income before income taxes was $35,545,000 compared to $12,736,000 a year ago. Net income was $20,789,000 or $0.38 basic and diluted per share compared to $7,339,000 or $0.14 basic and diluted per share a year ago. Cash provided by operations was $29,330,000 compared to $26,752,000 a year ago. Capital expenditures were $5,618,000 compared to $4,543,000 a year ago. EBITDA was $48,152,000 compared with $38,939,000 for the same period last year. Adjusted EBITDA was $54,392,000 compared to $43,053,000 a year ago. Non-GAAP income from continuing operations was $22,007,000 compared to $16,816,000 a year ago. Adjusted income from continuing operations was $30,632,000 or $0.56 per diluted share compared to $24,891,000 or $0.46 per diluted share a year ago. Income from continuing operations was $20,699,000 or $0.38 per diluted share against $7,243,000 or $0.13 per diluted share a year ago. For the six months period, the company reported revenues of $907,892,000 compared to $786,908,000 a year ago. Operating income was $65,930,000 compared to $54,630,000 a year ago. Income before income taxes was $59,499,000 compared to $30,495,000 a year ago. Net income was $34,706,000 or $0.63 diluted per share compared to $31,952,000 or $0.59 diluted per share a year ago. Cash provided by operations was $25,009,000 compared to $30,327,000 a year ago. Capital expenditures were $9,638,000 compared to $7,328,000 a year ago. EBITDA was $84,393,000 compared with $69,003,000 for the same period last year. Adjusted EBITDA was $94,598,000 compared to $76,257,000 a year ago. Non-GAAP income from continuing operations was $36,510,000 compared to $27,406,000 a year ago. Adjusted income from continuing operations was $53,776,000 or $0.98 per diluted share compared to $43,660,000 or $0.81 per diluted share a year ago. Income from continuing operations was $34,747,000 or $0.63 per diluted share against $17,459,000 or $0.32 per diluted share a year ago. The company provided earnings guidance for the third quarter of 2014. For the quarter, the company expects revenues of $479.0 million to $483.0 million, gross margin of 32.4% to 32.6%, SG&A expense (excludes amortization of intangible assets) of $108.0 to $109.0 million (includes $3.6 million in depreciation and $4.9 million in equity-based compensation expense), amortization of intangible assets of $6.2 million, adjusted EBITDA of $55.5 million to $57.0 million, effective tax rate of 41.6%, adjusted income from continuing operations of $30.7 million to $31.6 million, adjusted income from continuing operations per diluted share of $0.55 to $0.57, income from continuing operations of $22.1 million to $23.0 million, income from continuing operations per diluted share of $0.40 to $0.41, and diluted shares outstanding of 55.8 million. For the full year of 2014, the company expects earnings and adjusted EBITDA to be within previously announced estimates and expect revenues to be slightly (approximately 0.3%) below the low-end of previously announced full year estimates.

On Assignment Mulls Acquisitions

On Assignment Inc. (NYSE:ASGN) is seeking acquisitions. Peter Dameris, President and Chief Executive Officer, said, "We would love to continue to acquire businesses. We're having a lot of conversations, but it's just not happening as quickly as we're generating cash."

On Assignment Inc. Presents at Avondale Partners Healthcare 1-1 Conference, Aug-11-2014

On Assignment Inc. Presents at Avondale Partners Healthcare 1-1 Conference, Aug-11-2014 . Venue: Boston Harbor Hotel, Boston, Massachusetts, United States.

 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
ASGN:US $27.40 USD -0.15

ASGN Competitors

Market data is delayed at least 15 minutes.

Company Last Change
AMN Healthcare Services Inc $15.46 USD -0.75
Kforce Inc $19.76 USD +0.20
MedAssets Inc $21.56 USD +0.16
TrueBlue Inc $27.05 USD -0.30
USG People NV €9.99 EUR -0.085
View Industry Companies
 

Industry Analysis

ASGN

Industry Average

Valuation ASGN Industry Range
Price/Earnings 21.0x
Price/Sales 0.8x
Price/Book 2.2x
Price/Cash Flow 13.5x
TEV/Sales 0.6x
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact ON ASSIGNMENT INC, please visit www.onassignment.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.